Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO): Protocol for an Open-label Randomised Controlled Trial of Injectable Maintenance Buprenorphine With Personalised Psychosocial Intervention.

NCT05164549 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT05164549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05164549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO): Protocol for an Open-label Randomised Controlled Trial of Injectable Maintenance Buprenorphine With Personalised Psychosocial Intervention.
Lead sponsor
King's College London
Phase
Phase 3
Overall status
Completed
Start date
August 6, 2019
Completion date
March 1, 2023
Enrollment
342 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

opiate substitution treatment